
**METABOLOMIC PROFILING IDENTIFIES NEW ENDOGENOUS MARKERS OF TUBULAR SECRETORY CLEARANCE**<br>
Michael L. Granda, MD MS,<sup>1,2</sup> David K. Prince PhD,<sup>1,2</sup> Oliver Fiehn PhD,<sup>3</sup> Yan Chen, PhD,<sup>4</sup> Tanya Rajabi, BS,<sup>1,2</sup> Catherine K. Yeung, PharmD, PhD, MPH,<sup>2,5</sup> Andrew N. Hoofnagle MD PhD,<sup>6</sup> Bryan Kestenbaum, MD, MS.<sup>1,2</sup><br>

<sup>1</sup>University of Washington, Department of Medicine, Division of Nephrology, Seattle WA.<br>
<sup>2</sup>Kidney Research Institute, Seattle, WA.<br>
<sup>3</sup>West Coast Metabolomics Center, University of California, Davis, California.<br>
<sup>4</sup>Analysis Group, Los Angeles, CA.<br>
<sup>5</sup>Department of Pharmacy, University of Washington, Seattle, WA.<br>
<sup>6</sup>University of Washington, Department of Laboratory Medicine, Seattle, WA<br>

---

Metabolomics dataset<br>
Normalized peak heights for untargeted metabolomics, human plasma and urine<br>
Excel format<br>
